Roche

Graphic image of an arrow nailing the bullseye of a target
Biotech

Roche's oral SERD hits goal in adjuvant breast cancer phase 3

The interim analysis positions giredestrant for use in the adjuvant setting, setting Roche up to target an unoccupied niche of a competitive market.
Nick Paul Taylor Nov 18, 2025 9:16am
yellow traffic light

Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist

Nov 13, 2025 9:52am
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am
Space shuttle takes off on background of blue sky

Roche signs $2B pact to pilot Manifold's shuttles to the brain

Nov 3, 2025 8:45am
Compressor inhaler with childs mask and pocket device for asthmatics on background of table

Roche pens $1B deal for respiratory bispecific from China

Oct 30, 2025 5:04am
layoffs employees crossed off

Genentech lets 118 staffers go in another HQ layoff round

Oct 29, 2025 4:55pm